江苏省中医院
纸质出版:2016
移动端阅览
[1]仓志兰.凉血通瘀方治疗慢性每日头痛40例临床观察[J].中医杂志,2016,57(01):58-61.
CANG Zhilan. Clinical Observation on 40 Cases Chronic Daily Headache Treated with Liangxue Tongyu Decotion(凉血通瘀方)[J]. Journal of Traditional Chinese Medicine2016, 57(1): 58-61.
[1]仓志兰.凉血通瘀方治疗慢性每日头痛40例临床观察[J].中医杂志,2016,57(01):58-61. DOI: 10.13288/j.11-2166/r.2016.01.015.
CANG Zhilan. Clinical Observation on 40 Cases Chronic Daily Headache Treated with Liangxue Tongyu Decotion(凉血通瘀方)[J]. Journal of Traditional Chinese Medicine2016, 57(1): 58-61. DOI: 10.13288/j.11-2166/r.2016.01.015.
目的观察凉血通瘀方治疗慢性每日头痛的临床疗效及安全性。方法将80例慢性每日头痛患者随机分为治疗组和对照组各40例
治疗组给予凉血通瘀方口服
每日1剂;对照组给予普瑞巴林片口服
每次75 mg
每日2次
两组均治疗60天。比较两组临床疗效
并分别于治疗前、治疗30天、治疗60天观察两组患者头痛发作频率、头痛持续时间、疼痛程度及伴随焦虑和抑郁情况。结果两组患者头痛发作频率、持续时间、疼痛程度在治疗30天及60天均较治疗前明显下降(P<0.01)
且治疗组头痛发作频率和持续时间在治疗30天时较对照组明显减少(P<0.01)。治疗60天对照组焦虑状态的改善优于治疗组(P<0.01)。治疗组临床控制率(25.00%)及总有效率(97.50%)均高于对照组(分别为5.00%及92.50%)(P<0.01)。对照组共计8例患者出现不良反应
治疗组无明显不良反应。结论凉血通瘀方治疗慢性每日头痛疗效肯定
且安全性好。
Objective To observe the clinical efficacy and safety of Liangxue Tongyu Decoction( 凉血通瘀方) in the treatment of chronic daily headache. Methods Eighty cases of chronic daily headache patients were randomly divided into treatment group and control group
with 40 cases in each group. The treatment group was given Liangxue Tongyu Decoction
1 dose daily; the control group was given pregabalin tablets orally
75 mg each time
twice a day.Both groups were treated for 60 days
and the clinical efficacy were compared. The headache attack frequency
headache duration
pain degree and the accompanied anxiety and depression were observed before treatment
the 30 th day and the 60 th day of the treatment. Results The headache attack frequency
duration time and pain degree of the patients in two groups were significantly decreased at the 30 th day and the 60 th day of treatment compared with those before treatment( P < 0. 01). The headache attack frequency and duration time of headache in treatment group at the30 th day of treatment were significantly decreased compared with control group( P < 0. 01). The improvement of anxiety state at the 60 th day of the treatment in the control group was better than that in the treatment group( P < 0. 01). The clinical control rate( 25%) and total effective rate( 97. 50%) in the treatment group were higher than those in the control group( 5% and 92. 50% respectively
P < 0. 01). In the control group
there were 8 cases of adverse reactions
the treatment group had no obvious adverse reactions. Conclusion Liangxue Tongyu Decotion seems to have definite curative effect and good security in the treatment of chronic daily headache.
0
浏览量
171
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号